Johnson & Johnson to Resume Covid-19 Vaccine Trial

| |

Spread the love

US pharmacist Johnson & Johnson said on Friday that it is preparing to resume the clinical trial of its experimental vaccine against Covid-19, suspended last week after a volunteer fell ill.

J&J said it was “planning to resume recruitment” for the phase 3 trial, which began in late September and plans to include 60,000 participants.

“After a thorough evaluation of a serious medical incident experienced by a study participant, no clear cause has been identified,” the group said in a statement. “The company has found no evidence that the candidate vaccine caused the incident.”

Spread the love

NKR reported on battles in all directions of the Karabakh conflict zone

Trump announces normalization between Israel and Sudan


Leave a Comment